Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06319820
Title	A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer (MoonRISe-1)
Acronym	MoonRISe-1
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Janssen Research & Development, LLC
Indications	urinary bladder cancer
Therapies	Mitomycin C Gemcitabine Erdafitinib
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| POL \| ITA \| ISR \| GBR \| FRA \| ESP \| DNK \| DEU \| CZE \| BRA \| BEL \| AUT \| ARG